Thermo Fisher Scientific Inc. Announces Executive Changes
September 28, 2021 at 08:46 am EDT
Share
On September 23, 2021, Mark Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific Inc., notified the company of his decision to retire effective March 18, 2022, and Syed Jafry, Senior Vice President, Regions, notified the company of his decision to retire effective March 31, 2022. Also on September 23, 2021 the Board of Directors of the Company appointed Michel Lagarde, currently Executive Vice President, Executive Vice President and Chief Operating Officer, effective January 1, 2022. Mr. Lagarde, 47, was appointed Executive Vice President in September 2019. Mr. Lagarde was President of the company’s Pharma Services business from August 2017 to September 2019 and previously served as President of Patheon N.V. from May 2016 to May 2017, and President and Chief Operating Officer from May 2017 until its acquisition by the company in August 2017. Also on September 23, 2021, the Board of Directors of the company appointed Gianluca Pettiti, currently Senior Vice President and President of the company’s Specialty Diagnostics business, Executive Vice President, effective December 27, 2021. Mr. Pettiti, 43, was President of the company’s Biosciences business from January 2018 to October 2019 and previously led the company’s business in China from January 2015 to December 2017.
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows:
- laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.;
- diagnostics equipment and products (15.3%);
- scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.
Net sales break down by source of income into products sales (78.5%) and services (21.5%).
Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).